Wockhardt · NSE: WOCKPHARMA · BSE: 532300
Q1 FY27 results · Apr–Jun 2026
Wockhardt reported revenue from operations of ₹929.00 crore (up 25.9% from Q1 FY26) and net profit of ₹107.00 crore for Q1 FY27 (Apr–Jun 2026), on a consolidated basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 929.00 | 738.00 | +25.9% | 965.00 | −3.7% |
| Other income | 31.00 | 20.00 | +55.0% | 45.00 | −31.1% |
| Total income | 960.00 | 758.00 | +26.6% | 1,010.00 | −5.0% |
| Profit before tax | 116.00 | (109.00) | Turned profit | 189.00 | −38.6% |
| Net profit for the period | 107.00 | (108.00) | Turned profit | 164.00 | −34.8% |
| Attributable to shareholders of the company | 106.00 | (90.00) | Turned profit | 166.00 | −36.1% |
| EPS, basic (₹) | 6.55 | (5.53) | Turned profit | 10.23 | −36.0% |
| Net margin (%) | 11.5 | -14.6 | 17.0 |
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 561.00 | 413.00 | +35.8% | 516.00 | +8.7% |
| Other income | 33.00 | 25.00 | +32.0% | 55.00 | −40.0% |
| Total income | 594.00 | 438.00 | +35.6% | 571.00 | +4.0% |
| Profit before tax | 107.00 | 69.00 | +55.1% | 167.00 | −35.9% |
| Net profit for the period | 107.00 | 69.00 | +55.1% | 167.00 | −35.9% |
| EPS, basic (₹) | 6.62 | 4.25 | +55.8% | 10.29 | −35.7% |
| Net margin (%) | 19.1 | 16.7 | 32.4 |
Consolidated
- Filed with BSE
- 10 Aug 2026, 17:28 IST
- Board meeting
- 10 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2026, 17:28 IST
- Board meeting
- 10 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE